What Happened
- AIIMS New Delhi and the Indian Space Research Organisation (ISRO) signed a Memorandum of Understanding (MoU) on 9 March 2026 to collaborate on space medicine research.
- The MoU was signed between M. Srinivas, Director of AIIMS New Delhi, and Dinesh Kumar Singh, Director of ISRO's Human Space Flight Centre (HSFC).
- The agreement establishes a cooperative framework for both ground-based and space-based research across several domains of human physiology relevant to spaceflight.
- The collaboration is directly tied to India's Gaganyaan human spaceflight programme, India's first crewed mission to low Earth orbit.
Static Topic Bridges
Gaganyaan Mission — India's First Human Spaceflight Programme
Gaganyaan is India's indigenous human spaceflight mission, aimed at sending a crew of Indian astronauts to Low Earth Orbit (LEO) at approximately 400 km altitude for a mission of up to seven days. It represents the culmination of decades of incremental ISRO capability building and positions India as only the fourth country to independently develop crewed spaceflight capability, after the US, Russia, and China.
- Launch vehicle: LVM-3 (formerly GSLV Mk III), modified as Human-Rated LVM-3, with an integrated Crew Escape System for crew safety
- Crew module: Designed to carry 2–3 astronauts; 5.3-metric tonne capsule
- Target orbit: 400 km altitude, Low Earth Orbit
- Mission duration: Up to 7 days for crewed flight
- Four selected astronauts (Gaganaut candidates): Group Captain Prasanth Balakrishnan Nair, Group Captain Ajit Krishnan, Group Captain Angad Pratap, Wing Commander Shubhanshu Shukla — all Indian Air Force pilots
- Vyommitra: A female humanoid robot to fly in uncrewed test flights (G1) to simulate astronaut conditions
- Uncrewed test flights (G1, G2, G3) precede the crewed mission, currently planned no earlier than 2027
Connection to this news: The AIIMS-ISRO MoU directly supports Gaganyaan's crewed mission readiness. Medical expertise from AIIMS will help develop astronaut health protocols, pre-flight screening frameworks, and in-mission monitoring systems that ISRO's Human Space Flight Centre requires before any human is placed aboard a spacecraft.
Space Medicine — The Emerging Discipline
Space medicine is the branch of medicine that studies the physiological and psychological effects of the space environment on the human body. It encompasses the health challenges of microgravity, radiation exposure, isolation, and the physiological changes caused by living in a spacecraft environment. As spaceflight durations increase, the medical complexity grows — ranging from muscle and bone loss to cardiovascular and immune system changes.
- Key research areas under the AIIMS-ISRO MoU: human physiology in microgravity, cardiovascular and autonomic regulation, musculoskeletal health, microbiome and immunology, genomics and biomarkers, and behavioural health
- Microgravity effects: Fluid shifts toward the head, loss of bone mineral density (~1–2% per month), muscle atrophy, and altered circadian rhythms
- Radiation: Astronauts in LEO are exposed to increased cosmic radiation compared to ground level
- India's prior collaboration: ISRO had previously signed an MoU with SCTIMST (Sree Chitra Tirunal Institute for Medical Sciences and Technology) on space medicine research
Connection to this news: The AIIMS-ISRO agreement brings India's premier medical institution into the space medicine ecosystem. AIIMS contributes clinical research infrastructure, specialist doctors, and trial protocols; ISRO brings mission-specific requirements and access to simulation environments.
ISRO's Human Space Flight Centre (HSFC)
The Human Space Flight Centre is the nodal agency within ISRO responsible for coordinating all activities related to India's human spaceflight programme. Established in Bengaluru, it oversees astronaut training, crew module development, life support systems, and all mission parameters related to human safety in space.
- HSFC was established specifically to manage the Gaganyaan programme
- It coordinates with international partners: astronauts completed Phase 1 training in Russia in 2020; further training conducted in India at ISRO's facility in Bengaluru
- HSFC oversees the Crew Escape System, Environmental Control and Life Support System (ECLSS), and crew health monitoring protocols
- Collaborations with medical institutions like AIIMS and SCTIMST expand the human expertise pool for mission preparation
Connection to this news: The MoU was signed by HSFC's Director — signalling that this is not a peripheral research collaboration but a mission-critical partnership directly embedded within Gaganyaan's operational infrastructure.
Key Facts & Data
- MoU signed: 9 March 2026, between AIIMS New Delhi (Director M. Srinivas) and ISRO HSFC (Director Dinesh Kumar Singh)
- Research domains: Human physiology, cardiovascular and autonomic regulation, musculoskeletal health, microbiome and immunology, genomics and biomarkers, behavioural health
- Gaganyaan launch vehicle: Human-Rated LVM-3 (based on GSLV Mk III) with Crew Escape System
- Target orbit: 400 km LEO; mission duration up to 7 days
- Gaganyaan crewed mission currently expected no earlier than 2027
- India would become the 4th country to independently conduct human spaceflight
- Prior space medicine MoU: ISRO–SCTIMST (Thiruvananthapuram) — earlier collaboration precedent